Spray-on transdermal drug delivery systems

Bibliography

• Santos P, Watkinson AC, Hadgraft J, Lane ME. Influence of penetration enhancer on drug permeation from volatile formulations. Int J Pharm 2012;439(1-2):260-8
   PubMedGoogle Scholar
• Sartorelli P, Andersen HR, Angerer J, et al. Percutaneous penetration studies for risk assessment. Environ Toxicol Pharmacol 2000;8(2):133-52
   PubMed Web of Science ®Google Scholar
• Schoellhammer CM, Blankschtein D, Langer R. Skin permeabilization for transdermal drug delivery: recent advances and future prospects. Expert Opin Drug Deliv 2014;11(3):393-407
   PubMed Web of Science ®Google Scholar
• Sobanko JF, Miller CJ, Alster TS. Topical anesthetics for dermatologic procedures: a review. Dermatol Surg 2012;38(5):709-21
   PubMed Web of Science ®Google Scholar
• Leichtnam ML, Rolland H, Wuthrich P, Guy RH. Identification of penetration enhancers for testosterone transdermal delivery from spray formulations. J Control Release 2006;113(1):57-62
   PubMed Web of Science ®Google Scholar
• Yan L, Raphael AP, Zhu X, et al. Nanocomposite-strengthened dissolving microneedles for improved transdermal delivery to human skin. Adv Healthc Mater 2014;3(4):555-64
   PubMed Web of Science ®Google Scholar
• Zorec B, Becker S, Rebersek M, et al. Skin electroporation for transdermal drug delivery: the influence of the order of different square wave electric pulses. Int J Pharm 2013;457(1):214-23
   PubMed Web of Science ®Google Scholar
• Bayldon W, Narishetty S, De Rose G, et al. Effects of eight vehicles on transdermal lidocaine penetration in sheep skin in vitro. J Vet Pharmacol Ther 2014;37(2):151-60
   PubMed Web of Science ®Google Scholar
• Liu S, Jin MN, Quan YS, et al. Transdermal delivery of relatively high molecular weight drugs using novel self-dissolving microneedle arrays fabricated from hyaluronic acid and their characteristics and safety after application to the skin. Eur J Pharm Biopharm 2014;86(2):267-76
   PubMed Web of Science ®Google Scholar
• Lu WC, Chiang BH, Huang DW, Li PH. Skin permeation of D-limonene-based nanoemulsions as a transdermal carrier prepared by ultrasonic emulsification. Ultrason Sonochem 2014;21(2):826-32
   PubMed Web of Science ®Google Scholar
• Mohammadi-Samani S, Yousefi G, Mohammadi F, Ahmadi F. Meloxicam transdermal delivery: effect of eutectic point on the rate and extent of skin permeation. Iran J Basic Med Sci 2014;17(2):112-18
   Web of Science ®Google Scholar
• Thakkar PJ, Madan P, Lin S. Transdermal delivery of diclofenac using water-in-oil microemulsion: formulation and mechanistic approach of drug skin permeation. Pharm Dev Technol 2014;19(3):373-84
   PubMed Web of Science ®Google Scholar
• Wong TW. Electrical, magnetic, photomechanical and cavitational waves to overcome skin barrier for transdermal drug delivery. J Control Release 2014. [Epub ahead of print]
   Web of Science ®Google Scholar
• Yan L, Raphael AP, Zhu X, et al. Vaccine delivery: nanocomposite-strengthened dissolving microneedles for improved transdermal delivery to human skin (adv. Healthcare mater. 4/2014). Adv Healthc Mater 2014;3(4):462
   Google Scholar
• Saluja S, Kasha PC, Paturi J, et al. A novel electronic skin patch for delivery and pharmacokinetic evaluation of donepezil following transdermal iontophoresis. Int J pharm 2013;453(2):395-9
   PubMedGoogle Scholar
• Cassettari LL, Dias PC, Lucchesi AN, et al. Zinc sulphate administered by transdermal iontophoresis improves breaking strength of surgical wounds in skin of alloxan-induced diabetic rats. Acta Cir Bras 2013;28(8):601-6
   PubMed Web of Science ®Google Scholar
• Almirall M, Montana J, Escribano E, et al. Effect of d-limonene, alpha-pinene and cineole on in vitro transdermal human skin penetration of chlorpromazine and haloperidol. Arzneimittelforschung 1996;46(7):676-80
   PubMed Web of Science ®Google Scholar
• Marty JP. New trends in transdermal technologies: development of the skin patch. Menorest. Int J Gynaecol Obstet 1996;52(Suppl 1):S17-20
   Google Scholar
• Yerasi AB, Butts JD, Butts JD. Disposal of used fentanyl patches. Am J Health Syst Pharm 1997;54(1):85-6
   PubMed Web of Science ®Google Scholar
• LoVecchio F, Ramos L. Suicide by Duragesic transdermal fentanyl patch toxicity. Am J Emerg Med 2011;29(1):131 e1-2
   PubMedGoogle Scholar
• Woolf A, Burkhart K, Caraccio T, Litovitz T. Childhood poisoning involving transdermal nicotine patches. Pediatrics 1997;99(5):E4
   PubMedGoogle Scholar
• Bakshi A, Bajaj A, Malhotra G, et al. A novel metered dose transdermal spray formulation for oxybutynin. Indian J Pharm Sci 2008;70(6):733-9
   PubMed Web of Science ®Google Scholar
• Schumacher RJ, Gattermeir DJ, Peterson CA, et al. The effects of skin-to-skin contact, application site washing, and sunscreen use on the pharmacokinetics of estradiol from a metered-dose transdermal spray. Menopause 2009;16(1):177-83
   PubMed Web of Science ®Google Scholar
• Lu W, Luo H, Zhu Z, et al. Preparation and the biopharmaceutical evaluation for the metered dose transdermal spray of dexketoprofen. J Drug Deliv 2014;2014:697434
   Google Scholar
• Williams PL, Brooks JD, Inman AO, et al. Determination of physicochemical properties of phenol, p-nitrophenol, acetone and ethanol relevant to quantitating their percutaneous absorption in porcine skin. Res Commun Mol Pathol Pharmacol 1994;83(1):61-75
   Web of Science ®Google Scholar
• Santhanam A, Miller MA, Kasting GB. Absorption and evaporation of N,N-diethyl-m-toluamide from human skin in vitro. Toxicol Appl Pharmacol 2005;204(1):81-90
   PubMed Web of Science ®Google Scholar
• Kasting GB, Miller MA. Kinetics of finite dose absorption through skin 2: volatile compounds. J Pharm Sci 2006;95(2):268-80
   PubMed Web of Science ®Google Scholar
• Reid ML, Benaouda F, Khengar R, et al. Topical corticosteroid delivery into human skin using hydrofluoroalkane metered dose aerosol sprays. Int J Pharm 2013;452(1-2):157-65
   PubMed Web of Science ®Google Scholar
• Morton TL, Gattermeir DJ, Petersen CA, et al. Steady-state pharmacokinetics following application of a novel transdermal estradiol spray in healthy postmenopausal women. J Clin Pharm 2009;49(9):1037-46
   PubMed Web of Science ®Google Scholar
• Ibrahim SA, Li SK. Effects of solvent deposited enhancers on transdermal permeation and their relationship with Emax. J Control Release 2009;136(2):117-24
   PubMed Web of Science ®Google Scholar
• Lane ME, Hadgraft J, Oliveira G, et al. Rational formulation design. Int J Cosmet Sci 2012;34(6):496-501
   PubMed Web of Science ®Google Scholar
• Leichtnam ML, Rolland H, Wuthrich P, Guy RH. Formulation and evaluation of a testosterone transdermal spray. J Pharm Sci 2006;95(8):1693-702
   PubMed Web of Science ®Google Scholar
• Buster JE. Low-dose estradiol spray: a novel treatment for vasomotor instability in postmenopausal women. Women’s Health 2009;5(1):23-8
   Google Scholar
• Archer DF. Menopausal hot flashes are treated effectively by a transdermal, low-dose estradiol spray. Nat Clin pract Endocrinol metab 2009;5(1):18-19
   PubMedGoogle Scholar
• Moser K, Kriwet K, Kalia YN, Guy RH. Enhanced skin permeation of a lipophilic drug using supersaturated formulations. J Control Release 2001;73(2-3):245-53
   PubMed Web of Science ®Google Scholar
• Santos P, Watkinson AC, Hadgraft J, Lane ME. Formulation issues associated with transdermal fentanyl delivery. Int J Pharm 2011;416(1):155-9
   PubMedGoogle Scholar
• Santos P, Watkinson AC, Hadgraft J, Lane ME. Enhanced permeation of fentanyl from supersaturated solutions in a model membrane. Int J Pharm 2011;407(1-2):72-7
   PubMed Web of Science ®Google Scholar
• Jones SA, Reid ML, Brown MB. Determining degree of saturation after application of transiently supersaturated metered dose aerosols for topical delivery of corticosteroids. J Pharm Sci 2009;98(2):543-54
   PubMed Web of Science ®Google Scholar
• Iervolino M, Cappello B, Raghavan SL, Hadgraft J. Penetration enhancement of ibuprofen from supersaturated solutions through human skin. Int J Pharm 2001;212(1):131-41
   PubMed Web of Science ®Google Scholar
• Feldmann RJ, Maibach HI. Percutaneous penetration of steroids in man. J Invest dermatol 1969;52(1):89-94
   PubMed Web of Science ®Google Scholar
• Leveque N, Raghavan SL, Lane ME, Hadgraft J. Use of a molecular form technique for the penetration of supersaturated solutions of salicylic acid across silicone membranes and human skin in vitro. Int J Pharm 2006;318(1-2):49-54
   PubMedGoogle Scholar
• Raghavan SL, Trividic A, Davis AF, Hadgraft J. Effect of cellulose polymers on supersaturation and in vitro membrane transport of hydrocortisone acetate. Int J Pharm 2000;193(2):231-7
   PubMed Web of Science ®Google Scholar
• Reid ML, Jones SA, Brown MB. Transient drug supersaturation kinetics of beclamethasone dipropionate in rapidly drying films. Int J Pharm 2009;371:114-19
   PubMed Web of Science ®Google Scholar
• Santos P, Machado M, Watkinson AC, et al. The effect of drug concentration on solvent activity in silicone membranes. Int J Pharm 2009;377(1-2):70-5
   PubMedGoogle Scholar
• McAuley WJ, Lad MD, Mader KT, et al. ATR-FTIR spectroscopy and spectroscopic imaging of solvent and permeant diffusion across model membranes. Eur J Pharm 2010;74(2):413-19
   Web of Science ®Google Scholar
• Wester RC, Maibach HI, Bucks DA, et al. Percutaneous absorption of [14C]DDT and [14C]benzo[a]pyrene from soil. Toxicol Sci 1990;15(3):510-16
   Google Scholar
• Morimoto Y, Wada Y, Seki T, Sugibayashi K. In vitro skin permeation of morphine hydrochloride during the finite application of penetration-enhancing system containing water, ethanol and l-menthol. Biol Pharm Bull 2002;25(1):134-6
   PubMed Web of Science ®Google Scholar
• Coldman MF, Poulsen BJ, Higuchi T. Enhancement of percutaneous absorption by the use of volatile: nonvolatile systems as vehicles. J Pharm Sci 1969;58(9):1098-102
   PubMed Web of Science ®Google Scholar
• Oliveira G, Hadgraft J, Lane ME. The influence of volatile solvents on transport across model membranes and human skin. Int J Pharm 2012;435(1):38-49
   PubMed Web of Science ®Google Scholar
• Kasting GB. Kinetics of finite dose absorption through skin 1. Vanillylnonanamide. J Pharm Sci 2001;90(2):202-12
   PubMed Web of Science ®Google Scholar
• Vaddi HK, Ho PC, Chan YW, Chan SY. Oxide terpenes as human skin penetration enhancers of haloperidol from ethanol and propylene glycol and their modes of action on stratum corneum. Biol Pharm Bull 2003;26(2):220-8
   PubMed Web of Science ®Google Scholar
• Kim YC, Park JH, Ludovice PJ, Prausnitz MR. Synergistic enhancement of skin permeability by N-lauroylsarcosine and ethanol. Int J Pharm 2008;352(1-2):129-38
   PubMed Web of Science ®Google Scholar
• Lee CK, Uchida T, Kitagawa K, et al. Relationship between lipophilicity and skin permeability of various drugs from an ethanol/water/lauric acid system. Biol Pharm Bull 1994;17(10):1421-4
   PubMed Web of Science ®Google Scholar
• Smith EW, Maibach HI. Percutaneous penetration enhancers. 2nd edition. CRC Press; 2005
   Google Scholar
• Ibrahim SA, Li SK. Effects of chemical enhancers on human epidermal membrane: structure-enhancement relationship based on maximum enhancement (E(max)). J Pharm Sci 2009;98(3):926-44
   PubMed Web of Science ®Google Scholar
• Chantasart D, Sa-Nguandeekul P, Prakongpan S, et al. Comparison of the effects of chemical permeation enhancers on the lipoidal pathways of human epidermal membrane and hairless mouse skin and the mechanism of enhancer action. J Pharm Sci 2007;96(9):2310-26
   PubMed Web of Science ®Google Scholar
• Wearley L, Chien YW. Enhancement of the in vitro skin permeability of azidothymidine (AZT) via iontophoresis and chemical enhancer. Pharm Res 1990;7(1):34-40
   PubMed Web of Science ®Google Scholar
• Horita D, Todo H, Sugibayashi K. Effect of ethanol pretreatment on skin permeation of drugs. Biol Pharm Bull 2012;35(8):1343-8
   PubMed Web of Science ®Google Scholar
• Kirschner MH, Lang RA, Breuer B, et al. Transdermal resorption of an ethanol- and 2-propanol-containing skin disinfectant. Langenbecks Arch Surg 2009;394(1):151-7
   PubMed Web of Science ®Google Scholar
• Ibrahim SA, Li SK. Chemical enhancer solubility in human stratum corneum lipids and enhancer mechanism of action on stratum corneum lipid domain. Int J Pharm 2010;383(1-2):89-98
   PubMedGoogle Scholar
• Ibrahim SA, Li SK. Efficiency of fatty acids as chemical penetration enhancers: mechanisms and structure enhancement relationship. Pharm Res 2010;27(1):115-25
   PubMed Web of Science ®Google Scholar
• Zhai H, Ebel JP, Chatterjee R, et al. Hydration vs. skin permeability to nicotinates in man. Skin Res Technol 2002;8(1):13-18
   PubMed Web of Science ®Google Scholar
• Berardesca E, Fideli D, Borroni G, et al. In vivo hydration and water-retention capacity of stratum corneum in clinically uninvolved skin in atopic and psoriatic patients. Acta Derm Venereol 1990;70(5):400-4
   PubMed Web of Science ®Google Scholar
• Berardesca E, Maibach HI. Transepidermal water loss and skin surface hydration in the non invasive assessment of stratum corneum function. Derm Beruf Umwelt 1990;38(2):50-3
   PubMedGoogle Scholar
• Mak VH, Potts RO, Guy RH. Does hydration affect intercellular lipid organization in the stratum corneum? Pharm Res 1991;8(8):1064-5
   PubMed Web of Science ®Google Scholar
• Lichtman R. Perimenopausal hormone replacement therapy. J Nurse Midwifery 1991;36(1):30-48
   PubMedGoogle Scholar
• Meikle AW, Mazer NA, Moellmer JF, et al. Enhanced transdermal delivery of testosterone across nonscrotal skin produces physiological concentrations of testosterone and its metabolites in hypogonadal men. J Clin Endocrinol Metab 1992;74(3):623-8
   PubMed Web of Science ®Google Scholar
• Brincat MP. Hormone replacement therapy and the skin: beneficial effects: the case in favor of it. Acta Obstet Gynecol Scand 2000;79(4):244-9
   PubMed Web of Science ®Google Scholar
• Brincat MP. Hormone replacement therapy and the skin. Maturitas 2000;35(2):107-17
   PubMed Web of Science ®Google Scholar
• Parker S, Armitage M. Experience with transdermal testosterone replacement therapy for hypogonadal men. Clin Endocrinol 1999;50(1):57-62
   PubMed Web of Science ®Google Scholar
• Rozenbaum H. Advantages and disadvantages of estrogen treatment by transdermal or oral administration. Eur J Obstet Gynecol Reprod Biol 1996;65(1):33-7
   PubMed Web of Science ®Google Scholar
• Buster JE, Koltun WD, Pascual ML, et al. Low-dose estradiol spray to treat vasomotor symptoms: a randomized controlled trial. Obstet Gynecol 2008;111(6):1343-51
   PubMed Web of Science ®Google Scholar
• Morgan TM, O’Sullivan HM, Reed BL, Finnin BC. Transdermal delivery of estradiol in postmenopausal women with a novel topical aerosol. J Pharm Sci 1998;87(10):1226-8
   PubMed Web of Science ®Google Scholar
• Frenkel Y, Kopernik G, Lazer S, et al. Acceptability and skin reactions to transdermal estrogen replacement therapy in relation to climate. Maturitas 1994;20(1):31-6
   PubMed Web of Science ®Google Scholar
• Rozenbaum H, Birkhauser M, De Nooyer C, et al. Comparison of two estradiol transdermal systems (Oesclim 50 and Estraderm TTS 50). II. Local skin tolerability. Maturitas 1996;25(3):175-85
   PubMed Web of Science ®Google Scholar
• Rozenbaum H, Birkhauser M, De Nooyer C, et al. Comparison of two estradiol transdermal systems (Oesclim 50 and Estraderm TTS 50). I. Tolerability, adhesion and efficacy. Maturitas 1996;25(3):161-73
   PubMed Web of Science ®Google Scholar
• Hasler-Nguyen N, Fotopoulos G. Effect of rubbing on the in vitro skin permeation of diclofenac-diethylamine 1.16% gel. BMC Res Notes 2012;5:321
   PubMedGoogle Scholar
• Parker LU, Bergfeld WF. Virilization secondary to topical testosterone. Cleve Clin J Med 1991;58(1):43-6
   PubMed Web of Science ®Google Scholar
• Wang C, Berman N, Longstreth JA, et al. Pharmacokinetics of transdermal testosterone gel in hypogonadal men: application of gel at one site versus four sites: a General Clinical Research Center Study. J Clin Endocrinol metabol 2000;85(3):964-9
   PubMed Web of Science ®Google Scholar
• Testosterone topical solution (Axiron) for hypogonadism. Med Lett Drugs Ther 2011;53(1368):54-5
   PubMed Web of Science ®Google Scholar
• Fraser IS, Weisberg E, Kumar N, et al. An initial pharmacokinetic study with a Metered Dose Transdermal Systemfor delivery of the progestogen Nestorone as a possible future contraceptive. Contraception 2007;76(6):432-8
   PubMed Web of Science ®Google Scholar
• Sitruk-Ware R, Nath A, Mishell DRJr. Contraception technology: past, present and future. Contraception 2013;87(3):319-30
   PubMed Web of Science ®Google Scholar
• Dmochowski RR, Nitti V, Staskin D, et al. Transdermal oxybutynin in the treatment of adults with overactive bladder: combined results of two randomized clinical trials. World J Urol 2005;23(4):263-70
   PubMed Web of Science ®Google Scholar
• Sand P, Zinner N, Newman D, et al. Oxybutynin transdermal system improves the quality of life in adults with overactive bladder: a multicentre, community-based, randomized study. BJU Int 2007;99(4):836-44
   PubMed Web of Science ®Google Scholar
• Dmochowski RR, Sand PK, Zinner NR, et al. Comparative efficacy and safety of transdermal oxybutynin and oral tolterodine versus placebo in previously treated patients with urge and mixed urinary incontinence. Urology 2003;62(2):237-42
   PubMed Web of Science ®Google Scholar
• Goldfischer ER, Sand PK, Thomas H, Peters-Gee J. Efficacy and safety of oxybutynin topical gel 3% in patients with urgency and/or mixed urinary incontinence: A randomized, double-blind, placebo-controlled. study. Neurourol Urodyn 2013
   PubMedGoogle Scholar
• Staskin DR, Dmochowski RR, Sand PK, et al. Efficacy and safety of oxybutynin chloride topical gel for overactive bladder: a randomized, double-blind, placebo controlled, multicenter study. J Urol 2009;181(4):1764-72
   PubMed Web of Science ®Google Scholar
• Santos P, Watkinson AC, Hadgraft J, Lane ME. Oxybutynin permeation in skin: the influence of drug and solvent activity. Int J Pharm 2010;384(1-2):67-72
   PubMedGoogle Scholar
• Kim JW. Aspiration of fentanyl patch. J Addict Med 2010;4(4):244-5
   PubMed Web of Science ®Google Scholar
• Mrvos R, Feuchter AC, Katz KD, et al. Whole fentanyl patch ingestion: a multi-center case series. J Emerg Med 2012;42(5):549-52
   PubMed Web of Science ®Google Scholar
• D’Orazio JL, Fischel JA. Recurrent respiratory depression associated with fentanyl transdermal patch gel reservoir ingestion. J Emerg Med 2012;42(5):543-8
   PubMed Web of Science ®Google Scholar
• Dirschka T, Reich K, Bissonnette R, et al. An open-label study assessing the safety and efficacy of alitretinoin in patients with severe chronic hand eczema unresponsive to topical corticosteroids. Clin Experim Dermatol 2011;36(2):149-54
   PubMed Web of Science ®Google Scholar
• Hanh BD, Neubert RH, Wartewig S, Lasch J. Penetration of compounds through human stratum corneum as studied by Fourier transform infrared photoacoustic spectroscopy. J Control Release 2001;70(3):393-8
   PubMed Web of Science ®Google Scholar
• Tsai JC, Weiner N, Flynn GL, Ferry JJ. Drug and vehicle deposition from topical applications: localization of minoxidil within skin strata of the hairless mouse. Skin Pharmacol 1994;7(5):262-9
   PubMedGoogle Scholar
• Sand PK, Davila GW, Lucente VR, et al. Efficacy and safety of oxybutynin chloride topical gel for women with overactive bladder syndrome. Am J Obstet Gynecol 2012;206(2):168.e1-6
   PubMed Web of Science ®Google Scholar